Anixa Biosciences Inc — Cash Flow (NASDAQ:ANIX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities -6.18 M-4.94 M-6.49 M-6.21 M-7.33 M-7.17 M -7.17 M Cash from investing activities -305.79 K-3.92 M-10.73 M-5.6 M4.28 M4.87 M 4.87 M Cash from financing activities 9.41 M31.57 M452 K366 K3.42 M2.28 M 2.28 M Free cash flow -6.19 M-4.94 M-6.49 M-6.21 M-7.33 M-7.17 M -7.17 M

Nachrichten

Anixa reports promising survival data in ovarian cancer CAR-T trial

EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues - Anixa Biosciences (NASDAQ:ANIX)

Anixa Biosciences erhält Patent für Brustkrebs-Impfstoff in Mexiko

Anixa Biosciences receives Mexican patent for breast cancer vaccine

Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic

Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why - Anixa Biosciences (NASDAQ:ANIX)

Anixa meldet positive Phase-1-Ergebnisse für Brustkrebsimpfstoff

Anixa’s breast cancer vaccine shows positive Phase 1 results

Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript

Anixa Biosciences: WHO benennt CAR-T-Therapie gegen Eierstockkrebs/n

WHO approves name for Anixa’s ovarian cancer CAR-T therapy

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?